生物股份
(600201)
| 流通市值：88.51亿 | | | 总市值：88.51亿 |
| 流通股本：11.20亿 | | | 总股本：11.20亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 351,572,845.58 | 1,255,455,757.88 | 970,804,600.73 | 611,731,208.51 |
| 营业收入 | 351,572,845.58 | 1,255,455,757.88 | 970,804,600.73 | 611,731,208.51 |
| 二、营业总成本 | 283,520,948.56 | 1,120,584,380.13 | 775,774,038.75 | 471,488,520.43 |
| 营业成本 | 159,875,470.45 | 579,326,374.56 | 425,238,182.58 | 257,398,609.38 |
| 税金及附加 | 2,783,880.33 | 21,829,242.01 | 13,409,812.39 | 10,767,291.68 |
| 销售费用 | 52,718,290.67 | 289,209,903.79 | 194,238,768.85 | 109,356,751.22 |
| 管理费用 | 41,099,013.16 | 143,129,426.2 | 92,752,560.71 | 59,904,181.66 |
| 研发费用 | 39,703,032.62 | 136,817,966.01 | 88,026,265.74 | 58,451,141.65 |
| 财务费用 | -12,658,738.67 | -49,728,532.44 | -37,891,551.52 | -24,389,455.16 |
| 其中:利息费用 | 443,915.94 | 5,502,260.49 | 5,126,997.83 | 4,726,553.72 |
| 其中:利息收入 | 13,090,375.82 | 55,355,612.38 | 43,121,201.51 | 29,183,607.02 |
| 加:公允价值变动收益 | -87,588.45 | 2,815,245.68 | 275,368.51 | 164,423.14 |
| 加:投资收益 | 13,980,823.8 | -12,301,592.56 | -6,936,195.01 | -5,229,610.34 |
| 资产处置收益 | -59,901.27 | 2,575,161.17 | 128,837.55 | 108,173.18 |
| 资产减值损失(新) | 2,019,000.92 | -31,072,325.92 | -14,663,574.21 | -8,568,920.37 |
| 信用减值损失(新) | 1,336,853.59 | -30,658,471.01 | -236,365.61 | 9,758,601.87 |
| 其他收益 | 10,860,501.5 | 58,434,975.42 | 20,266,943.73 | 10,562,402.4 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 96,101,587.11 | 124,664,370.53 | 193,865,576.94 | 147,037,757.96 |
| 加:营业外收入 | 28,038.93 | 1,517,702.83 | 454,389.64 | 415,889.4 |
| 减:营业外支出 | 164,166.5 | 1,271,758.57 | 733,788.88 | 393,683.51 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 95,965,459.54 | 124,910,314.79 | 193,586,177.7 | 147,059,963.85 |
| 减:所得税费用 | 18,762,845.19 | 20,756,222.15 | 23,330,156.7 | 23,450,785.6 |
| 六、净利润 | 77,202,614.35 | 104,154,092.64 | 170,256,021 | 123,609,178.25 |
| 持续经营净利润 | 77,202,614.35 | 104,154,092.64 | 170,256,021 | 123,609,178.25 |
| 归属于母公司股东的净利润 | 76,481,084.9 | 108,985,186.46 | 169,540,956.58 | 122,918,629.44 |
| 少数股东损益 | 721,529.45 | -4,831,093.82 | 715,064.42 | 690,548.81 |
| (一)基本每股收益 | 0.07 | 0.1 | 0.15 | 0.11 |
| (二)稀释每股收益 | - | - | 0.15 | 0.11 |
| 八、其他综合收益 | 41,680,353.86 | -74,369,451.27 | -7,695,409.94 | 3,746,795.87 |
| 归属于母公司股东的其他综合收益 | 41,680,340.64 | -74,358,315.24 | -7,703,240.99 | 3,751,083.92 |
| 九、综合收益总额 | 118,882,968.21 | 29,784,641.37 | 162,560,611.06 | 127,355,974.12 |
| 归属于母公司股东的综合收益总额 | 118,161,425.54 | 34,626,871.22 | 161,837,715.59 | 126,669,713.36 |
| 归属于少数股东的综合收益总额 | 721,542.67 | -4,842,229.85 | 722,895.47 | 686,260.76 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |